참고문헌
- Aleem E, Elshayeb A, Elhabachi N, et al (2012). Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncol Lett, 3, 704-12. https://doi.org/10.3892/ol.2011.546
- Arikawa AY, Kurzer MS, Thomas W, et al (2010). No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 19, 2987-90. https://doi.org/10.1158/1055-9965.EPI-10-0828
- Ascensao A, Magalhães J, Soares J, et al (2005). Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol, 100, 451-60. https://doi.org/10.1016/j.ijcard.2004.11.004
- Ascensao A, Magalhaes J, Soares J, et al (2006). Endurance exercise training attenuates morphological signs of cardiac muscle damage induced by doxorubicin in male mice. Basic Appl Myol, 16, 27-35.
- Ascensão A, Oliveira PJ, Magalhaes J (2012). Exercise as a beneficial adjunct therapy during Doxorubicin treatment—Role of mitochondria in cardioprotection. Int J Cardiol, 156, 4-10. https://doi.org/10.1016/j.ijcard.2011.05.060
- Cao H, Wang G, Meng L, et al (2012). Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One, 7, 49884. https://doi.org/10.1371/journal.pone.0049884
- Chicco AJ, Schneider CM, Hayward R (2005). Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol, 289, 424-43. https://doi.org/10.1152/ajpregu.00636.2004
- Chicco AJ, Hydock DS, Schneider CM, et al (2006), Hayward R. Low-intensity exercise training during doxorubicin treatment protects againstcardiotoxicity, J Appl Physiol, 100, 519-27. https://doi.org/10.1152/japplphysiol.00148.2005
- Chicco AJ, Schneider CM, Hayward R(2006). Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol, 47, 182-9. https://doi.org/10.1097/01.fjc.0000199682.43448.2d
- Dabidi Roshan V, Assali M, HajizadehMoghaddamAk, et al (2011). Exercise training and antioxidants: Effects on rat heart tissue exposed to lead acetate. Int J Toxicol, 30, 190-6. https://doi.org/10.1177/1091581810392809
- Dragojevic-Simic VM, Dobric SL, Bokonjic DR, et al (2004). Amifostine protection against doxorubicin cardiotoxicity in rats. Anticancer Drugs, 15, 169-78.
- Dziegiel P, Surowiak P, Zabel M (2002). Correlation of histopathological and biochemical appraisal of anthracyclininduced myocardium damage. Folia Histochem Cytobiol, 40, 127-8.
- Friedenreich CM, Neilson HK, Woolcott CG, et al (2011). Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer, 18, 357-69. https://doi.org/10.1530/ERC-10-0303
- Guo YS, Jin GF, Houston CW, et al (1998). Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cells. J Cell Physiol, 175, 141-8. https://doi.org/10.1002/(SICI)1097-4652(199805)175:2<141::AID-JCP3>3.0.CO;2-O
- HHydock DS, Lien CY, Schneider CM, et al (2008). Exercise preconditioning protects against doxorubicin induced cardiac dysfunction. Med Sci Sports Exerc, 40, 808-17. https://doi.org/10.1249/MSS.0b013e318163744a
- Ibrahim SS, Barakat MA,Helmy HS (2010). Modulating Effect of Carvedilol on Doxorubicin-Induced Cardiomyopathy and Hepatic Damage. J Am Sci, 6, 20-32.
- Kalyanaraman B, Joseph J, Kalivendi S, et al (2002). Doxorubicininduced apoptosis: implications in cardiotoxicity. Mol Cell Biochem, 234, 119-24.
- Kavazis AN, Smuder AJ, Min K, et al (2010). Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72. Am J Physiol Heart Circ Physiol, 5, 1515-24.
- Kelishomi RB, Ejtemaeemehr S, Tavangar SM et al(2008). Morphine is protective against doxorubicin-induced cardiotoxicity in rat. J Appl Toxicol, 243, 96-100. https://doi.org/10.1016/j.tox.2007.09.026
- King PD, Perry MC (2001). Hepatotoxicity of chemotherapy. Oncologist, 6, 162-76. https://doi.org/10.1634/theoncologist.6-2-162
- Ludke AR, Al-Shudiefat AA, Dhingra S, et al (2009). A concise description of cardioprotective strategies in doxorubicininduced cardiotoxicity. Can J PhysiolPharmacol, 87, 756-63. https://doi.org/10.1139/Y09-059
- Sprod LK, Janelsins MC, Palesh OG, et al (2012). Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan. J Cancer Surviv, 6, 146-54. https://doi.org/10.1007/s11764-011-0205-7
- Wang G, Zhang J, Liu L et al(2012). Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer throughp53/Bcl-xl. PLoS One, 7, 51764. https://doi.org/10.1371/journal.pone.0051764
- Wonders KY, Hydock DS, Greufe S, et al (2009). Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974. Cancer Chemother Pharmacol, 64, 1105-13. https://doi.org/10.1007/s00280-009-0967-z
- Wonders KY, Hydock DS, Schneider CM, et al (2008). Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther, 7, 147-54. https://doi.org/10.1177/1534735408322848
- Xu M, Sheng L, Zhu X, et al (2010). Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats. Tumori, 96, 460-4. https://doi.org/10.1177/030089161009600314
- Yen HC, Oberley TD, Vichitbandha S, et al (1996). Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest, 98, 1253-60. https://doi.org/10.1172/JCI118909
- Zumkeller W (2001). IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol, 54, 285-8. https://doi.org/10.1136/mp.54.5.285
피인용 문헌
- Induction of Apoptosis by IGFBP3 Overexpression in Hepatocellular Carcinoma Cells vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10085
- Age-related effect of aerobic exercise training on antioxidant and oxidative markers in the liver challenged by doxorubicin in rats vol.52, pp.7, 2018, https://doi.org/10.1080/10715762.2018.1470328